PEAK PHARMACEUTICALS, INC. Deferred Income Tax Expense (Benefit)
PEAK PHARMACEUTICALS, INC. (RMHI) reported Deferred Income Tax Expense (Benefit) of -$170.10 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2016-01-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2016-01-13
- PEAK PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2015 was -$170.10K.
- PEAK PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2014 was -$381.90K.
- PEAK PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2013 was -$4.90K.
- PEAK PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2012 was -$8.05K.
| Period end | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2015-09-30 | -$170.10K 10-K · filed 2016-01-13 | |
| 2014-09-30 | -$381.90K 10-K · filed 2016-01-13 | |
| 2013-09-30 | -$4.90K 10-K · filed 2015-01-12 | -$4.91K 10-K · filed 2013-12-27 |
| 2012-09-30 | -$8.05K 10-K · filed 2013-12-27 |